Recurrent/Refractory Multidrug- and Pre-Multidrug-Resistant Pseudomonas aeruginosa Infection Cases Maintained by Long-Term, Low-Dose Macrolide Administration
Clinical Pharmacology: Advances and Applications · 2026-05 · Volume 18 · 1-7
DOI: 10.2147/cpaa.s600235 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Pharmacology: Advances and Applications, 2026-05. Verfasst von Masafumi Seki. Beteiligte Einrichtung: Division of Infectious Diseases and Infection Control, Saitama Medical University International Medical Center, Hidaka City, Saitama, Japan. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Infectious Diseases and Infection Control, Saitama Medical University International Medical Center, Hidaka City, Saitama, Japan.
ORCID-Profile: Masafumi Seki
Zitieren
APA
Seki, M. (2026). Recurrent/Refractory Multidrug- and Pre-Multidrug-Resistant Pseudomonas aeruginosa Infection Cases Maintained by Long-Term, Low-Dose Macrolide Administration. Clinical Pharmacology: Advances and Applications, Volume 18, 1-7. https://doi.org/10.2147/cpaa.s600235
Vancouver
Seki M. Recurrent/Refractory Multidrug- and Pre-Multidrug-Resistant Pseudomonas aeruginosa Infection Cases Maintained by Long-Term, Low-Dose Macrolide Administration. Clinical Pharmacology: Advances and Applications. 2026;Volume 18:1-7. doi:10.2147/cpaa.s600235
BibTeX
@article{Seki2026,
author = {Seki, Masafumi},
title = {Recurrent/Refractory Multidrug- and Pre-Multidrug-Resistant Pseudomonas aeruginosa Infection Cases Maintained by Long-Term, Low-Dose Macrolide Administration},
journal = {Clinical Pharmacology: Advances and Applications},
year = {2026},
volume = {Volume 18},
pages = {1--7},
doi = {10.2147/cpaa.s600235}
}
EUVIMED